HSP70 is actively released as exosome surface protein under the stimulation of high levels of IL-10 and IFN-γ in the serum of cancer patients, suggesting the role of exosomal HSP70 in tumor immunity and the potential of HSP70 as a cancer biomarker (121). Here, IL10 is linked to cancer.